logo
Select company
Select metric
0.7%Capital Expenditures Margin
VS
Market
86
Sector
79
Industry
76
History
92
$ 9.72Close
$ 6.07 - $ 28.04 52-Week Range
Ticker Information

Ticker

ARVN

Company Name

ARVINAS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

ARVINAS INC - Capital Expenditures Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

ARVN - CapEx % Historical data
DateCapital ExpenditureCapital Expenditures MarginRevenues
6/30/2025$ 2.6M0.7%$ 372.8M
3/31/2025$ 2M0.47%$ 426.9M
12/31/2024$ 1.7M0.65%$ 263.4M
9/30/2024$ 1.5M0.93%$ 161.1M
6/30/2024$ 1.9M2.04%$ 93.3M
3/31/2024$ 1.9M2.66%$ 71.3M
12/31/2023$ 2.9M3.69%$ 78.5M
9/30/2023$ 3.9M2.33%$ 167.2M
6/30/2023$ 5M3.07%$ 162.9M
3/31/2023$ 5.8M4.15%$ 139.7M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • ARVINAS INC's latest trailing twelve months (TTM) CapEx % stands at 26.07%.
  • Over the past 5 years, ARVINAS INC's average CapEx % has been 9.33%.
  • The median CapEx % for ARVINAS INC during this period was 4.66%
  • ARVINAS INC reached its highest CapEx % over the past 5 years at 29.57%.
  • The lowest CapEx % recorded by ARVINAS INC in the same timeframe 0.47%

ARVINAS INC's CapEx % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CapEx % Benchmarks
CompanyCapEx %
RIGL : RIGEL PHARMACEUTICALS INC -MRVI : MARAVAI LIFESCIENCES HOLDINGS INC 9.02%KROS : KEROS THERAPEUTICS INC 0.84%SNDA : SONIDA SENIOR LIVING INC 8.69%CSTL : CASTLE BIOSCIENCES INC 8.06%RGNX : REGENXBIO INC 1.81%XNCR : XENCOR INC 3.24%ANGO : ANGIODYNAMICS INC 3.1%NKTR : NEKTAR THERAPEUTICS -KURA : KURA ONCOLOGY INC 2.55%

Definition of Capital Expenditures Margin

[Calculation] The CapEx Margin, also named Capex to Revenue Ratio, measures how much of a company’s revenue is reinvested into productive [Assets]. It is capital expenditures [CapEx] divided by [Revenue].
CapEx / Revenues
(=) CapEx %
CapEx % for ARVINAS INC is calculated as follows: CapEx [ $ 6.38M ] / Revenues [ $ 24.48M ]
(=) CapEx % [ 26.07% ]

ARVN - Capital Expenditures Margin, Last 5 years

0.47%

Minimum

Mar 31, 2025

29.57%

Maximum

Dec 31, 2020

9.33%

Average

4.66%

Median

CapEx % Benchmark Analysis

The chart above depicts the distribution of CapEx % for companies in the Total Stock Market. The average CapEx % of the companies is 3.46% with a standard deviation of 3.27%.
The following table provides additional summary stats:
CapEx % in the Market:
filtered constituents2.85K
min0%
max15.04%
average3.46%
median2.43%
std3.27%